152 results
Page 2 of 8
8-K
EX-99.1
lu6gv3mkk5v
7 May 21
Entry into a Material Definitive Agreement
7:09am
425
EX-99.1
6glq8qxio 621q6k1sr
7 May 21
Business combination disclosure
7:08am
8-K
EX-99.1
3slgh
17 Sep 20
Acasti Appoints Seasoned Executive Brian D. Ford CPA-CA as Chief Financial Officer
9:54pm
8-K
8flfy908z4 yubpk
17 Sep 20
Acasti Appoints Seasoned Executive Brian D. Ford CPA-CA as Chief Financial Officer
9:54pm
8-K
EX-99.1
6zfot
13 Aug 20
Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2021
8:30am
8-K
EX-99.1
rksbhue84l4s7ydy 8s
31 Jul 20
Regulation FD Disclosure
4:05pm
10-K
0xqtdf5l vxrjrhio
29 Jun 20
Annual report
4:02pm
8-K
EX-99.1
n4g d5chfatgeiy8t5t
29 Jun 20
Acasti Pharma Provides Fiscal 2020 Year-End Business Update
12:50pm
8-K
EX-99.1
w4b2t1
19 Jun 20
Acasti Pharma Receives FDA Response to TRILOGY 1 Briefing Package
9:09am
8-K
EX-99.1
504hm77
30 Apr 20
Acasti Pharma Announces Submission of TRILOGY 1 Briefing Package to FDA
4:22pm
8-K
EX-99.1
80tj27da eu2lrpbgg
20 Apr 20
Acasti Pharma Awarded Notice of Allowance for Second Composition of Matter Patent in Canada
4:05pm
8-K
EX-99.1
pbujk
1 Apr 20
Acasti Pharma Submits FDA Meeting Request on Schedule, and FDA Meeting Expected in the Second Half of June
5:12pm
6-K
EX-99.1
puzcew
11 Mar 20
Acasti Pharma Awarded Notice of Allowance for Additional Composition of Matter and Method of Use Patents in the United States and Mexico
8:00am
6-K
EX-99.1
p0og29y9
28 Feb 20
Acasti Receives NASDAQ Notification Regarding Minimum Bid Requirements
5:00pm
6-K
EX-99.1
pcsnvqk3a
14 Feb 20
Current report (foreign)
8:00am
6-K
EX-99.1
96skfif6h x7yw3
14 Feb 20
Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2020
8:00am
6-K
EX-99.1
gvkc odg23q7yt6znjf
13 Feb 20
Acasti Pharma Schedules Third Quarter Fiscal 2020 and Business Update Conference Call
9:00am
6-K
EX-99.1
3t5idkhyntgu6yabp1u
10 Feb 20
Acasti Pharma Provides Update on TRILOGY 1 and TRILOGY 2 Phase 3 Trials of CaPre
7:00am
6-K
EX-99.1
ild0ynztxxps7lzg3e
13 Jan 20
Acasti Pharma Reports Topline Results for TRILOGY 1 Phase 3 Trial of CaPre
6:21am